top of page
Eyecelerator @ AAO 2022 - RETINA SHOWCASES
Moderators: Robert L. Avery, MD and Allen C. Ho, MD
Panel: Wiley A. Chambers, MD; Lori-Ann Christie, PhD; Paul Hallen, MS; Firas M. Rahhal, MD; Namrata Saroj, OD
Start | Company | Presenter |
|---|---|---|
2:00 PM | Ocular Therapeutix | Peter K. Kaiser, MD, Chief Medical Advisor for Retina |
2:05 PM | Clearside Biomedical | Thomas Ciulla, MD, MBA, Chief Medical and Development Officer |
2:10 PM | EyePoint Pharmaceuticals, Inc | Jay S. Duker, MD, COO |
2:15 PM | Discussion | |
2:23 PM | Pixium Vision | Ralf Horning, PhD, Director, Clinical Affairs |
2:28 PM | AGTC | Sue Washer, President & CEO |
2:33 PM | Kiora | Eric J. Daniels, MD, Chief Development Officer |
2:38 PM | Discussion | |
2:46 PM | Outlook Therapeutics | Russell Trenary, President & CEO |
2:51 PM | NanoScope | Samarendra Mohanty, President |
2:56 PM | Nvasc | Daniel Schwartz, MD, Co-Founder, Director |
3:01 PM | Discussion | |
3:09 PM | LumiThera, Inc. | Clark E. Tedford, PhD, President & CEO |
3:14 PM | Visotec GmbH | Helge Sudkamp, CEO |
3:19 PM | GelMEDIX | Arthur Driscoll, Chief Development Officer |
3:24 PM | Discussion | |
3:32 PM | Unity Biotechnology | Anirvan Ghosh, PhD, CEO |
3:37 PM | Oculis S.A. | Riad Sherif, MD, CEO |
3:42 PM | OcuTerra Therapeutics | Kerrie Brady, CEO & President |
3:47 PM | Discussion |
bottom of page